Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.

Ljungvall I, Höglund K, Lilliehöök I, Oyama MA, Tidholm A, Tvedten H, Häggström J.

J Vet Intern Med. 2013 Sep-Oct;27(5):1105-12. doi: 10.1111/jvim.12137. Epub 2013 Jul 19.

2.

Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.

Cremer SE, Singletary GE, Olsen LH, Wallace K, Häggström J, Ljungvall I, Höglund K, Reynolds CA, Pizzinat N, Oyama MA.

J Vet Intern Med. 2014 Sep-Oct;28(5):1534-40. doi: 10.1111/jvim.12420. Epub 2014 Aug 21.

3.

Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.

Mangklabruks T, Surachetpong SD.

J Vet Cardiol. 2014 Sep;16(3):155-62. doi: 10.1016/j.jvc.2014.05.003. Epub 2014 Jul 28.

PMID:
25127665
4.

Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.

Cremer SE, Kristensen AT, Reimann MJ, Eriksen NB, Petersen SF, Marschner CB, Tarnow I, Oyama MA, Olsen LH.

Am J Vet Res. 2015 Jun;76(6):520-31. doi: 10.2460/ajvr.76.6.520.

PMID:
26000599
5.

Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.

Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Elliott J.

Am J Vet Res. 2012 Nov;73(11):1765-74. doi: 10.2460/ajvr.73.11.1765.

PMID:
23106462
6.

Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.

Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.

J Vet Intern Med. 2012 Jan-Feb;26(1):76-84. doi: 10.1111/j.1939-1676.2011.00842.x. Epub 2011 Dec 13.

7.

Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.

Madsen MB, Olsen LH, Häggström J, Höglund K, Ljungvall I, Falk T, Wess G, Stephenson H, Dukes-McEwan J, Chetboul V, Gouni V, Proschowsky HF, Cirera S, Karlskov-Mortensen P, Fredholm M.

J Hered. 2011 Sep-Oct;102 Suppl 1:S62-7. doi: 10.1093/jhered/esr041.

PMID:
21846748
8.

Radial and longitudinal strain and strain rate assessed by speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.

Zois NE, Tidholm A, Nägga KM, Moesgaard SG, Rasmussen CE, Falk T, Häggström J, Pedersen HD, Åblad B, Nilsen HY, Olsen LH.

J Vet Intern Med. 2012 Nov-Dec;26(6):1309-19. doi: 10.1111/j.1939-1676.2012.01017.x. Epub 2012 Nov 1.

9.

Serum serotonin concentrations in dogs with degenerative mitral valve disease.

Arndt JW, Reynolds CA, Singletary GE, Connolly JM, Levy RJ, Oyama MA.

J Vet Intern Med. 2009 Nov-Dec;23(6):1208-13. doi: 10.1111/j.1939-1676.2009.0378.x. Epub 2009 Aug 26.

10.

Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.

Cremer SE, Moesgaard SG, Rasmussen CE, Zois NE, Falk T, Reimann MJ, Cirera S, Aupperle H, Oyama MA, Olsen LH.

Res Vet Sci. 2015 Jun;100:197-206. doi: 10.1016/j.rvsc.2015.03.020. Epub 2015 Mar 19.

PMID:
25843893
11.

Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.

Tidholm A, Höglund K, Häggström J, Ljungvall I.

J Vet Intern Med. 2015 Nov-Dec;29(6):1510-7. doi: 10.1111/jvim.13609. Epub 2015 Sep 14.

12.

Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.

Eriksson AS, Häggström J, Pedersen HD, Hansson K, Järvinen AK, Haukka J, Kvart C.

J Vet Cardiol. 2014 Sep;16(3):141-54. doi: 10.1016/j.jvc.2014.05.001. Epub 2014 Jul 23.

PMID:
25130405
13.

Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs.

Ljungvall I, Höglund K, Tidholm A, Olsen LH, Borgarelli M, Venge P, Häggström J.

J Vet Intern Med. 2010 Jan-Feb;24(1):153-9. doi: 10.1111/j.1939-1676.2009.0428.x.

14.

Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.

Zois NE, Olsen NT, Moesgaard SG, Rasmussen CE, Falk T, Häggström J, Pedersen HD, Møller JE, Olsen LH.

J Vet Intern Med. 2013 Jul-Aug;27(4):875-83. doi: 10.1111/jvim.12114. Epub 2013 Jun 3.

15.

R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.

Reimann MJ, Møller JE, Häggström J, Markussen B, Holen AE, Falk T, Olsen LH.

Vet J. 2014 Mar;199(3):348-54. doi: 10.1016/j.tvjl.2014.01.001. Epub 2014 Jan 11.

PMID:
24507881
16.

Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.

Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM.

Am J Vet Res. 2017 Apr;78(4):440-446. doi: 10.2460/ajvr.78.4.440.

PMID:
28345991
17.

Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.

Moesgaard SG, Klostergaard C, Zois NE, Teerlink T, Molin M, Falk T, Rasmussen CE, Luis Fuentes V, Jones ID, Olsen LH.

J Vet Intern Med. 2012 Jan-Feb;26(1):61-8. doi: 10.1111/j.1939-1676.2011.00846.x. Epub 2011 Dec 13.

18.

Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.

Ljungvall I, Rajamäki MM, Crosara S, Olsen LH, Kvart C, Borgarelli M, Höglund K, Häggström J.

Am J Vet Res. 2011 Aug;72(8):1022-8. doi: 10.2460/ajvr.72.8.1022.

PMID:
21801058
19.

Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Borgarelli M, Abbott J, Braz-Ruivo L, Chiavegato D, Crosara S, Lamb K, Ljungvall I, Poggi M, Santilli RA, Haggstrom J.

J Vet Intern Med. 2015 Mar-Apr;29(2):569-74. doi: 10.1111/jvim.12564.

20.

Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease.

Tidholm A, Höglund K, Häggström J, Bodegård-Westling A, Ljungvall I.

J Vet Intern Med. 2013 Jul-Aug;27(4):884-9. doi: 10.1111/jvim.12113. Epub 2013 Jun 3.

Supplemental Content

Support Center